Bacterial News and Research

RSS

Exciton, ULURU sign agreement to develop and market Altrazeal exSALT product

ULURU Inc. announced today that it has signed a Binding Letter of Intent with Exciton Technologies Inc. to develop and market a product that will combine Altrazeal® with Exciton's proprietary exSALT™ Antimicrobial Technology.

20 Jan 2011

AMBR sensor measures growth and drug susceptibility of bacterial cells without use of microscope

With an invention that can be made from some of the same parts used in CD players, University of Michigan researchers have developed a way to measure the growth and drug susceptibility of individual bacterial cells without the use of a microscope.

19 Jan 2011

Forest Laboratories third quarter net sales increase 6.7% to $1,063.9 million

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $1.11 in the third quarter of fiscal 2011 after taking a charge for a new product licensing fee of $66.1 million or $0.23 per share, net of tax.

18 Jan 2011

Vaccine to prevent MRSA infections after bone and joint surgery

University of Rochester Medical Center orthopaedic scientists are a step closer to developing a vaccine to prevent life-threatening methicillin-resistant staphylococcus aureus (MRSA) infections following bone and joint surgery.

18 Jan 2011

Cataloguing microbes in gut could lead to cause of necrotizing enterocolitis

Scientists have for the first time sequenced and reconstructed the genomes of most of the microbes in the gut of a premature newborn and documented how the microbe populations changed over time.

14 Jan 2011

Study reports long-term complications in childhood survivors of bacterial meningitis

Nearly half of children who survive an episode of bacterial meningitis experience persistent behavioral, intellectual, or other complications, reports a study in the January issue of The Pediatric Infectious Disease Journal.

14 Jan 2011

Bill and Melinda Gates Foundation grants $1.5million to Liverpool University for bacterial study

A University of Liverpool-led consortium has received $1.5million from the Bill & Melinda Gates Foundation to study a bacterium that causes serious disease and epidemics in sub-Saharan Africa.

14 Jan 2011

AAAS elevates Dartmouth professors to rank of Fellow

The American Association for the Advancement of Science (AAAS) has elevated four Dartmouth professors to the rank of Fellow, including three members of the faculty of Dartmouth Medical School.

13 Jan 2011

Antibiotics need to be used only when diagnosis of acute ear infection is certain

A new study showed that antibiotics are more effective than previously thought in the treatment of acute ear infection (namely acute otitis media) in young children. However, half of the children became better without antibiotics. Expectedly, antibiotics caused more adverse events. Antibiotics should be used only when the diagnosis of acute ear infection is certain.

13 Jan 2011

SDIX receives FDA method equivalency and AOAC-RI certification for Salmonella Enteritidis test system

SDIX, a leading supplier of rapid detection solutions to the $1 billion food pathogen testing market, today announced that its RapidChek® SELECT™ Salmonella Enteritidis (SE) test system has been reviewed by the U.S. Food and Drug Administration (FDA) and determined to be equivalent in accuracy, precision and sensitivity to their current standard methods for poultry house environmental drag swabs and pooled egg testing.

13 Jan 2011

Antibiotic treatment may be sufficient to overcome River Blindness

The team found that a bacterium inside the worm acts as a 'disguise' for the parasite, resulting in the immune system reacting to it in an ineffective way. The bacteria protect the worm from the body's natural defences, but once the bacteria are removed with antibiotics, the immune system responds appropriately, releasing cells, called eosinophils, that kill the worm.

13 Jan 2011

Rib-X raises $20M to support development of broad spectrum antibiotics pipeline

Rib-X Pharmaceuticals, Inc. today announced that the Company has raised $20 million to support ongoing development of the Company's industry-leading broad spectrum antibiotics pipeline, including late-stage clinical development of delafloxacin, which is expected to enter a Phase 2b study in early 2011.

11 Jan 2011

OraSure to introduce QuickFlu test for detection of type A and type B influenza

OraSure Technologies, announced today the impending launch of the OraSure QuickFlu Rapid Flu A+B Test, a U.S. Food and Drug and Administration approved in vitro rapid qualitative test for the detection of influenza type A and type B, including H1N1 viral infections.

11 Jan 2011

BiAqua, DSM enter partnership for strain and process development of BiAqua Ferritin

DSM BioSolutions, Royal DSM's microbial fermentation contract manufacturing business, and BiAqua B.V., an innovator in delivering bio-based solutions for serious water contamination issues, today announced that they have entered into an agreement for strain development, process development and production of "BiAqua Ferritin" for BiAqua's core technology to address bio-fouling and arsenic contamination in the water sector.

11 Jan 2011

Predator microbes may work against antibiotic resistant disease-causing bacteria: Study

There are predators in the bacterial world that consume other bacteria, much as predators attack prey in the animal world. A team led by researchers at the University of Medicine and Dentistry of New Jersey-New Jersey Dental School suggests that some of these predator microbes might be put to work against disease-causing bacteria that have become resistant to antibiotics.

11 Jan 2011

Tips for surviving a bout with 'stomach flu'

A post-holiday crush of patients are crowding into area physician offices and hospital emergency rooms as individuals of all ages suddenly find themselves laid low by a highly contagious and quick-striking virus.

10 Jan 2011

Study compares treatment cost of PID hospitalizations, ER care for teen girls

Hospitalizing teen girls with pelvic inflammatory disease costs six times as much as treating them in the emergency room, and up to 12 times more than treating them in an outpatient clinic, according to a small study conducted at the Johns Hopkins Children's Center.

6 Jan 2011

Columbia research team identifies bacteria may play a key role in atherosclerosis

Dr. Emil Kozarov and a team of researchers at the Columbia University College of Dental Medicine have identified specific bacteria that may have a key role in vascular pathogenesis, specifically atherosclerosis, or what is commonly referred to as "hardening of the arteries" - the number one cause of death in the United States.

6 Jan 2011

Bacteria adopt defence strategy to promote antibiotic resistance

Genetic resistance to antibiotics is not the only trick bacteria use to resist eradication- they also have a second defence strategy known as persistence that can kick in.

6 Jan 2011

ODS enters license agreement with Enox Biopharma to develop novel treatment for periodontal disease

Enox Biopharma, a leader in the development of innovative solutions for infections associated with medical devices, and Ortho Dental Solutions LTD today announced an execution of an exclusive royalty bearing license agreement under which Enox Biopharma shall grant Ortho Dental Solutions LTD rights to patent application and knowhow for use in developing novel therapies limited in use for dental and gum diseases.

6 Jan 2011

Bacterial News and Research

Exciton, ULURU sign agreement to develop and market Altrazeal exSALT product

AMBR sensor measures growth and drug susceptibility of bacterial cells without use of microscope

Forest Laboratories third quarter net sales increase 6.7% to $1,063.9 million

Vaccine to prevent MRSA infections after bone and joint surgery

Cataloguing microbes in gut could lead to cause of necrotizing enterocolitis

Study reports long-term complications in childhood survivors of bacterial meningitis

Bill and Melinda Gates Foundation grants $1.5million to Liverpool University for bacterial study

AAAS elevates Dartmouth professors to rank of Fellow

Antibiotics need to be used only when diagnosis of acute ear infection is certain

SDIX receives FDA method equivalency and AOAC-RI certification for Salmonella Enteritidis test system

Antibiotic treatment may be sufficient to overcome River Blindness

Rib-X raises $20M to support development of broad spectrum antibiotics pipeline

OraSure to introduce QuickFlu test for detection of type A and type B influenza

BiAqua, DSM enter partnership for strain and process development of BiAqua Ferritin

Predator microbes may work against antibiotic resistant disease-causing bacteria: Study

Tips for surviving a bout with 'stomach flu'

Study compares treatment cost of PID hospitalizations, ER care for teen girls

Columbia research team identifies bacteria may play a key role in atherosclerosis

Bacteria adopt defence strategy to promote antibiotic resistance

ODS enters license agreement with Enox Biopharma to develop novel treatment for periodontal disease

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News